Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines

Frontiers in Immunology
January 13, 2022
Cited by 26


Related Papers

No related papers found

Powered by citation graph analysis